News
14h
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.
The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results